2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Colitis in 3 studies
2,2-bis(4-glycidyloxyphenyl)propane: structure
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rosiglitazone was administrated to animals at the dose of 8 mg/kg four times via an intra-gastric probe." | 5.36 | Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats. ( Celinski, K; Cichoz-Lach, H; Czechowska, G; Dworzanski, T; Korolczuk, A; Madro, A; Radej, S; Slomka, M, 2010) |
| "Rosiglitazone was administrated to animals at the dose of 8 mg/kg four times via an intra-gastric probe." | 1.36 | Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats. ( Celinski, K; Cichoz-Lach, H; Czechowska, G; Dworzanski, T; Korolczuk, A; Madro, A; Radej, S; Slomka, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dworzanski, T | 2 |
| Celinski, K | 2 |
| Korolczuk, A | 2 |
| Slomka, M | 2 |
| Radej, S | 1 |
| Czechowska, G | 1 |
| Madro, A | 2 |
| Cichoz-Lach, H | 1 |
| Piasecki, R | 1 |
| Fornal, R | 1 |
| Berruyer, C | 1 |
| Pouyet, L | 1 |
| Millet, V | 1 |
| Martin, FM | 1 |
| LeGoffic, A | 1 |
| Canonici, A | 1 |
| Garcia, S | 1 |
| Bagnis, C | 1 |
| Naquet, P | 1 |
| Galland, F | 1 |
3 other studies available for 2,2-bis(4-glycidyloxyphenyl)propane and Colitis
| Article | Year |
|---|---|
Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
Topics: Animals; Benzhydryl Compounds; Colitis; Cytokines; Epoxy Compounds; Intestine, Large; PPAR gamma; Ra | 2010 |
Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Carcinogens; Colitis; Colon; Cytokines; Dextran Sul | 2011 |
Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
Topics: Active Transport, Cell Nucleus; Amidohydrolases; Animals; Benzhydryl Compounds; Body Weight; Cell Ad | 2006 |